Back to Search
Start Over
Amelioration of the Development of Osteoarthritis by Daily Intake of β-Cryptoxanthin
- Source :
- Biological & Pharmaceutical Bulletin. 40:1116-1120
- Publication Year :
- 2017
- Publisher :
- Pharmaceutical Society of Japan, 2017.
-
Abstract
- β-Cryptoxanthin, which is primarily obtained from citrus fruits such as Satsuma mandarins, is a major carotenoid routinely found in human serum. Recently, we demonstrated that daily oral intake of β-cryptoxanthin prevented ovariectomy-induced bone loss and ameliorated neuropathic pain in mice. Although β-cryptoxanthin exerts preventive effects on various lifestyle-related diseases, there have been no studies on the effect of β-cryptoxanthin on the development of osteoarthritis, the most common degenerative joint disease, which frequently leads to loss of ability and stiffness in the elderly. Here we showed that daily oral administration of β-cryptoxanthin significantly prevented the development of osteoarthritis developed by surgically inducing knee joint instability in mice in vivo. Furthermore, in vitro experiments revealed that β-cryptoxanthin markedly inhibited the expression of inflammatory cytokines and enzymes critical for the degradation of the extracellular matrix in primary chondrocytes. Our results suggest that oral supplementation of β-cryptoxanthin would be beneficial for the maintenance of joint health and as prophylaxis against osteoarthritis.
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Beta-Cryptoxanthin
Pharmaceutical Science
Osteoarthritis
Chondrocyte
Proinflammatory cytokine
Extracellular matrix
Mice
03 medical and health sciences
Chondrocytes
0302 clinical medicine
Oral administration
In vivo
Internal medicine
medicine
Animals
030203 arthritis & rheumatology
Pharmacology
business.industry
General Medicine
medicine.disease
In vitro
030104 developmental biology
Endocrinology
medicine.anatomical_structure
Neuropathic pain
Cytokines
Inflammation Mediators
business
Subjects
Details
- ISSN :
- 13475215 and 09186158
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- Biological & Pharmaceutical Bulletin
- Accession number :
- edsair.doi.dedup.....ad6c32e8ebe43836e6b31bfa21db3daf
- Full Text :
- https://doi.org/10.1248/bpb.b17-00161